Form 10-Q Adaptive Biotechnologies For: Jun 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/10/2026
- S&P 500, Nasdaq futures slip as investors eye SK Hynix listing, Middle East risks
- Oil heads for weekly gain as Middle East supply risks persist
- Software stocks slide as Starbucks builds AI tools to replace vendor software
- Applied Materials surges as CEO signals multi-year chip boom
- Oil prices settle 2% lower as economic worries outweigh supply risks
- Key things to know ahead of SK Hynix’s blockbuster US listing
- Meta falls as massive AI infrastructure spending plans overshadow chip progress
- S&P Downgrades Oracle To 'bbb-/A-3'; Outlook Stable
- Software stocks slide as Starbucks builds AI tools to replace vendor software
- Citi names top picks in software ahead of Q2 earnings
Adeptus Biotechnologies Corp. (ADPT) PT Raised to $11 at Morgan Stanley
August 6, 2025 7:56 AM EDTMorgan Stanley analyst Tejas Savant raised the price target on Adeptus Biotechnologies Corp. (NASDAQ: ADPT) to $11.00 (from $9.00) while maintaining a Equalweight rating.
The analyst comments "Another solid beat/raise as clonoSEQ volume/ASP momentum continues on payor traction, community/EMR uptake; MRD EBITDA... More
